Clover Health Investments Crop. ($CLOV) Stock Forecast: Up 5.3% Today

What is Clover Health Investments Crop.?

Clover Health Investments (CLOV) is a company that primarily focuses on Medicare Advantage. Recent growth in membership and optimistic projections for profitability in 2026 have been noted.

Why is Clover Health Investments Crop. going up?

CLOV stock is up 5.3% on Jan 22, 2026 16:50

• The rise in CLOV stock could be linked to the CEO's recent share sales, potentially indicating confidence in the company's future.
• Upbeat forecasts for profitability in 2026 and an annual increase in Medicare Advantage membership likely boosted investor confidence and led to the stock's upward movement.
• Despite a lack of profitability over the past year, the expectation of turning profitable this year and being deemed slightly undervalued by InvestingPro could have additionally stimulated investor interest in CLOV.

CLOV Price Chart

CLOV Technical Analysis

CLOV News

Clover Health CEO Reynoso sells $11860 in shares

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, sold 4,597 shares of Class A Common Stock for $11,860 on January 20, 2026, and an additional 14,732 shares for $41,396 on January 15, 2026, to cover tax obligations. Despite not being profitable in the past year, InvestingPro analysis anticipates Clover Health will achieve profitability this year, with a projected GAAP Net Income profitability in 2026. The company also reported a 53% year-over-year increase in Medicare Advantage membership and its stock is considered slightly undervalued by InvestingPro.

https://www.investing.com/news/insider-trading-news/clover-health-ceo-reynoso-sells-11860-in-shares-93CH-4456579

Trending Today

ZCash ($ZEC) Crypto Forecast: Up 5.4% Today

Clover Health Investments Crop. Price History

23.09.2025 - CLOV Stock was up 5.5%

• Participation in a global healthcare conference suggests potential positive developments or strategic partnerships for Clover Health.
• Investors may interpret the conference participation as a signal of industry recognition and future growth prospects for the company.
• The rise in CLOV's stock price could be linked to increased investor confidence after the announcement of the CFO's presentation at the conference.
• Market participants could be expecting favorable insights or announcements during the conference, leading to a surge in CLOV's stock price.

05.10.2025 - CLOV Stock was down 27.8%

• The bearish movement in CLOV could be attributed to the disappointing earnings report for Q3, with the company reporting break-even earnings and missing revenue expectations.
• Investors might be concerned about the company's future growth prospects, as indicated by the negative earnings surprise.
• The market reaction could also reflect uncertainty about Clover Health Investments' ability to maintain its competitive edge in the healthcare technology sector.
• Overall, the bearish trend in CLOV today could be a result of investors reevaluating the stock's valuation in light of the underwhelming financial performance in the recent quarter.

22.00.2026 - CLOV Stock was up 5.3%

• The rise in CLOV stock could be linked to the CEO's recent share sales, potentially indicating confidence in the company's future.
• Upbeat forecasts for profitability in 2026 and an annual increase in Medicare Advantage membership likely boosted investor confidence and led to the stock's upward movement.
• Despite a lack of profitability over the past year, the expectation of turning profitable this year and being deemed slightly undervalued by InvestingPro could have additionally stimulated investor interest in CLOV.

06.10.2025 - CLOV Stock was down 7.2%

• Highlighting CLOV as a great choice for value investors due to recent strong momentum and reasonable prices might have attracted a lot of attention and buying interest.
• Break-even earnings for Q3 with negative surprises on earnings and positive surprises on revenue could have led to disappointment among investors, causing a sell-off and contributing to the bearish movement.
• Mixed signals from market participants, expecting momentum but receiving disappointing earnings clues, likely resulted in increased volatility and downward pressure on CLOV's stock price.

07.04.2025 - CLOV Stock was up 10.4%

• CLOV exceeded Q1 earnings estimates significantly, reflecting robust financial performance.
• A notable earnings surprise of 171.43% and revenue beat of 3.06% likely enhanced investor confidence in the company's growth potential.
• This robust financial showing could attract more investor attention and fuel the uptrend in CLOV's stock price.
• Investors may have a positive outlook on CLOV's future based on these impressive earnings outcomes.

01.07.2025 - CLOV Stock was down 5.9%

• Vicky Bruner's recent appointment as Vice President of Operations at Counterpart Health, a Clover Health subsidiary, suggests a strategic focus on expansion and enhancing operational efficiency.
• Despite this promising development, reactions from investors to the announcement may have been negative, potentially reflecting concerns about market sentiment or internal challenges faced by the company.
• The downward movement in CLOV's stock price could be attributed to broader market dynamics or selling pressure from traders capitalizing on previous price increases.

16.04.2025 - CLOV Stock was up 8.0%

• Clover Health (CLOV) stock showed a significant uptrend today.
• The rise in CLOV stock is linked to its strong Q1 results, indicating improved profitability that has fostered greater confidence among investors.
• The favorable performance of CLOV mirrors the positive outlook in the healthcare sector, as investors show optimism towards the growth potentials of companies in healthcare technology.
• When compared to Atossa Genetics Inc. (ATOS) in the medical sector, CLOV's superior performance has heightened investor interest in the stock.

08.06.2025 - CLOV Stock was up 8.8%

• CLOV stock saw a significant increase, with share prices rising notably.
• The upcoming second-quarter earnings report set for August 5th may be influencing investor confidence and attention towards the stock.
• Expectations of favorable financial outcomes or strategic updates in the earnings report could be driving the recent strong performance of CLOV stock.
• Investor response to potential growth opportunities or internal advancements within the company could be boosting the stock's upward trajectory.

06.07.2025 - CLOV Stock was down 22.9%

• Q2 earnings of Clover Health were in line with expectations, with a 34% revenue increase.
• Despite this, the stock declined as the company raised its Insurance BER guidance, sparking worries about margin pressures.
• The adverse outlook on insurance benefits expense ratio (BER) appears to have unsettled investors, resulting in the bearish trend in CLOV's stock price.

23.08.2025 - CLOV Stock was up 7.9%

• CLOV is still considered undervalued, making it an appealing option for investors seeking promising stocks at reasonable prices.
• The bullish movement in CLOV is seen as an opportunity for investors looking for growth potential at an attractive price.
• This positive momentum reflects optimism among investors about Clover Health Investments' future prospects, leading to an increase in its stock price.
• The bullish movement in CLOV today could be linked to growing investor interest and favorable sentiment regarding the company's potential for growth.

09.04.2025 - CLOV Stock was down 9.0%

• Despite surpassing Q1 earnings estimates, Clover Health (CLOV) experienced a bearish movement.
• The strong bearish movement could be attributed to profit-taking by investors who had seen a significant surge in the stock price over the past year.
• Market sentiment might have shifted due to concerns about sustainability of profitability or future growth prospects despite the positive earnings report.
• Investors may have reacted to broader market trends or sector-specific news impacting health insurance companies, leading to the bearish movement in Clover Health's stock price today.

22.06.2025 - CLOV Stock was up 7.7%

• Participation in the Canaccord Genuity 45th Annual Growth Conference could have positively influenced investor sentiment towards Clover Health.
• The conference presents an opportunity for Clover Health to highlight its growth strategies and future developments, potentially boosting investor confidence.
• Speculation about the conference yielding valuable insights and partnerships likely contributed to today's bullish trend in CLOV stock.